Ephedrine 25 Guaifenesin (ephedrine recalls
The FDA has published 1 recall involving Ephedrine 25 Guaifenesin (ephedrine since 2022. The latest was reported on 16 Feb 2022. Most were for manufacturing (cgmp) deviations. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls1since 2022
Last 12 months0reported
Class I00% of total
Ongoing0latest 16 Feb 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why ephedrine 25 guaifenesin (ephedrine is recalled
Companies
By year
All ephedrine 25 guaifenesin (ephedrine recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Ephedrine 25 Guaifenesin (Ephedrine HCl 25 mg recalled | ULTRAtab Laboratories | Manufacturing (CGMP) Deviations | NY |
Should you stop taking Ephedrine 25 Guaifenesin (ephedrine?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.